Healthcare -
Biotechnology - NASDAQ - US
$ 2.12
10.4 %
$ 147 M
Market Cap
-0.68
P/E
IKT - TOTAL CURRENT ASSETS
Total Current Assets IKT - Inhibikase Therapeutics, Inc.
14.2 M
LAST VALUE
-42.15%
2 YEAR CAGR
62.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR